Endoscopic Sphincterotomy With Balloon Dilatation Versus Sphincterotomy Alone For Common Bile Duct Stones Removal
Launched by HOSPITAL UNIVERSITI SAINS MALAYSIA · Nov 25, 2022
Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
Endoscopic sphincterotomy (EST) is most widely used during endoscopic retrograde cholangiopancreatography (ERCP) to remove common bile duct (CBD) stone and considered as standard therapy for treatment of choledocholithiasis. However, in view of EST requires an adequate incision on major duodenal papilla to achieve biliary cannulation, it can potentially cause damage to biliary sphincter during the procedure and potentially increased risk of some complications such as bleeding and biliary reflux. This procedure carries risk of complications such as haemorrhage, perforation, and long-term eff...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient's age 18 and above
- • 2. Patient with CBD stone documented on imaging studies
- Exclusion Criteria:
- • 1. CBD stone size more than 15mm
- • 2. CBD stone number more than 3
- • 3. Concurrent hepatobiliary tumour
- • 4. Intrahepatic stone
- • 5. Bleeding tendencies: coagulopathy, thrombocytopenia, patient on anticoagulant medication
- • 6. Patient in sepsis/ Cholangitis patient
- • 7. Patient with acute pancreatitis
- • 8. Prior history of Bilroth II or Roux-en-y surgery
About Hospital Universiti Sains Malaysia
Hospital Universiti Sains Malaysia (HUSM) is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. Affiliated with Universiti Sains Malaysia, HUSM integrates education, research, and patient care to foster a multidisciplinary approach to medical research. The hospital is committed to enhancing patient outcomes and contributing to the global medical community by conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. Through its state-of-the-art facilities and a team of experienced healthcare professionals, HUSM aims to explore new therapeutic options and improve existing treatment modalities across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kubang Kerian, Kelantan, Malaysia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials